[18F]Fluoroethyl triazole labelled [Tyr3]-Octreotate analogue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]Fluoroethyl triazole labelled [Tyr3]-Octreotate analogue, covering 2025-05-01 to 2025-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours. [Phase 1, Phase 2]